Par Drugs And Chemicals: The financial results for the period ended September 30, 2026
Par Drugs And Chemicals (PAR) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹149 crore.
What happened
Par Drugs And Chemicals (PAR) filed a disclosure with the exchanges on 29 October 2026 at 05:01 PM titled "The financial results for the period ended September 30, 2026".
From the filing: "Par Drugs And Chemicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026."
Company snapshot
Par Drugs And Chemicals is a micro-cap company, with a market value of about ₹149 crore.
The stock last traded at ₹120.7, against a 52-week range of ₹78.05–₹180 (32.9% below the high).
Before this filing the shares had moved −12.5% over the month and +19.9% over three months. Average daily turnover over the last 20 sessions was about ₹0.11 crore.
Promoters held 73.41% at the end of Q1 FY27.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 26 | 3.3 | 2.7 |
| Q2 FY26 | 29 | 4.1 | 3.36 |
| Q3 FY26 | 29 | 4.8 | 3.9 |
| Q4 FY26 | 20 | 0.9 | 0.69 |
| Q1 FY27 | 31 | 4.7 | 3.83 |
What history shows
This is not the company's first results disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.
Market-wide, 9,836 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 29 October 2026: Board meeting — Financial Results/Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.